Glenn J. Jaffe

Active 1986–2025

123
Papers
23,765
Citations
80
h-index
120
i10-index

Citations

Citations per year for Glenn J. Jaffe1965: 1 citations1986: 1 citations1987: 4 citations1988: 4 citations1989: 2 citations1990: 2 citations1991: 2 citations1992: 1 citations1993: 3 citations1994: 1 citations1995: 2 citations1996: 1 citations1997: 4 citations1998: 4 citations1999: 13 citations2000: 13 citations2001: 20 citations2002: 33 citations2003: 26 citations2004: 45 citations2005: 60 citations2006: 62 citations2007: 44 citations2008: 46 citations2009: 39 citations2010: 74 citations2011: 63 citations2012: 60 citations2013: 113 citations2014: 153 citations2015: 163 citations2016: 153 citations2017: 172 citations2018: 175 citations2019: 716 citations2020: 932 citations2021: 1,082 citations2022: 783 citations2023: 663 citations2024: 1,226 citations2025: 505 citations2026: 10 citations1966–1985: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,028 citing papers, 26.6% of this breakdownUnited Kingdom: 641 citing papers, 8.4% of this breakdownChina: 463 citing papers, 6.1% of this breakdownGermany: 452 citing papers, 5.9% of this breakdownItaly: 402 citing papers, 5.3% of this breakdownSwitzerland: 325 citing papers, 4.3% of this breakdownAustralia: 324 citing papers, 4.2% of this breakdownJapan: 306 citing papers, 4% of this breakdownFrance: 298 citing papers, 3.9% of this breakdownSpain: 200 citing papers, 2.6% of this breakdownCanada: 177 citing papers, 2.3% of this breakdownIndia: 172 citing papers, 2.3% of this breakdown
0%26.6%Other 24.1%

Fields

  • Medicine82%
  • Biochemistry, Genetics and Molecular Biology10.4%
  • Immunology and Microbiology2.5%
  • Neuroscience1.8%
  • Engineering1.2%
  • Pharmacology, Toxicology and Pharmaceutics0.8%
  • Other1.3%

Topics

  • Retinal Diseases and Treatments22.6%
  • Retinal Imaging and Analysis9.8%
  • Ocular Diseases and Behçet’s Syndrome8.9%
  • Ophthalmology and Visual Impairment Studies5.6%
  • Glaucoma and retinal disorders4.8%
  • Retinal Development and Disorders4.8%
  • Other43.5%

Coauthors

All papers

Open in search
  1. Consensus Definition for Atrophy Associated with Age-Related Macular Degeneration on OCT

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Ophthalmology 2017 cited by 872

  2. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Elisa E. Cornish, Thanh N. Nguyen, Oliver Findl, Anton Haas, Martina Kralinger, Stefan Sacu, Laurence Postelmans, Michel Eid Farah, Maurício Maia, Márcio Bittar Nehemy, Fareed Ali, Michael H. Brent, Michael Dollin, John R. Gonder, Amin Kherani, Andrew Merkur, Raman Tuli, Monica Marie Lopera, Francisco J. Rodríguez, Mario Bradvica, Jan Ernest, Kuldar Kalijurand, Kai Noor, Yves Cohen, Catherine Creuzot‐Garcher, F. De Bats, François Devin, Catherine Français-Maury, Laurent Kodjikian, Jean François Korobelnik, Y. Le Mer, M. Quaranta El Maftouhi, Sam Razavi, Eric H. Souied, Ramin Tadayoni, Michel Weber, Nicole Eter, Nicolas Feltgen, Salvatore Grisanti, Peter Walter, Raffael Liegl, Katrin Lorenz, Georg Spital, Siegfried Priglinger, Martin S. Spitzer, Michael Völker, Tim U. Krohne, Claudia Jochmann, Chris P. Lohmann, Carsten Framme, Ágnes Kerényi, András Papp, András Seres, Edit Tóth‐Molnár, Alexis Tsorbatzoglou, A VAJAS, Balázs Varsányi, Gábor Vogt, Asaf Bar, Eva Eting, David Hauser, Jamie Levy, Nurit Mathalone, Haia Morori-Katz, Irit Rosenblatt, Shiri Soudry-Zayit, Omert Trivizky, Francesco Bandello, Antonio P. Ciardella, Michele Figus and 126 more - The Lancet 2023 cited by 315

  3. Consensus Nomenclature for Reporting Neovascular Age-Related Macular Degeneration Data

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karl G. Csaky, Jordi Monés, Daniel Pauleikhoff, Ramin Tadayoni, James G. Fujimoto - Ophthalmology 2019 cited by 791

  4. HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration

    Authors: , , , , , , , , , - Ophthalmology 2019 cited by 911

  5. C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration

    Authors: , , , , , , , , , - Ophthalmology 2020 cited by 446

  6. Incomplete Retinal Pigment Epithelial and Outer Retinal Atrophy in Age-Related Macular Degeneration

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Ophthalmology 2019 cited by 296

  7. Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration

    Authors: , , , , , , , , - Ophthalmology 2016 cited by 705

  8. HAWK and HARRIER

    Authors: , , , , , , , , , - Ophthalmology 2020 cited by 371

  9. Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration

    Authors: , , , , , , , , - Ophthalmology 2012 cited by 1,711

  10. Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial

    Authors: , , , , , , , , , , - Eye 2023 cited by 130

  11. Risk of Inflammation, Retinal Vasculitis, and Retinal Occlusion–Related Events with Brolucizumab

    Authors: , , , , , , , , , , , - Ophthalmology 2020 cited by 349

  12. Adalimumab in Patients with Active Noninfectious Uveitis

    Authors: , , , , , , , , , , , , , , , , - New England Journal of Medicine 2016 cited by 659

  13. Faricimab Treat-and-Extend for Diabetic Macular Edema

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Suhail Alam, Arturo Alezzandrini, Virgil Alfaro, Daniel Aliseda, Arghavan Almony, Pedro Amat, Payam Amini, Andrew N. Antoszyk, Luís Arias, Riaz Asaria, Marcos Pereira de Ávila, Carl C. Awh, Joaquín Bafalluy, Carl W. Baker, Francesco Bandello, Mark Barakat, Karen Barraza, György Bátor, Caroline R. Baumal, Rubens Belfort, Chris Bergstrom, George Bertolucci, Thomas W. Bochow, Matthias Bolz, Emilia Borcz, Arnaldo Furman Bordon, David S. Boyer, Galina Bratko, Michael H. Brent, Jamin S. Brown, David M. Brown, M V Budzinskaya, S. Buffet, Stuart C Burgess, Ben Burton, Miguel Busquets, Francisco Cabrera, Carlo Cagini, Jorge I. Calzada, Peter A. Campochiaro, John S. Carlson, Alessandro Castellarin, Carlos Eduardo Cava, Voraporn Chaikitmongkol, Clement Chan, Emmanuel Chang, Jonathan S. Chang, Andrew Chang, Steve Charles, Nauman Chaudhry, Caroline Chee, Judy Chen, Fred K. Chen, Shih‐Jen Chen, Richard Cheong-Leen, Allen Chiang, Mark Chittum, David R. Chow, B. Connolly, Pierre Loïc Cornut, Karl G. Csaky, Carl J. Danzig, Arup Das, Vesselin Daskalov, Carmen Desco, Amr Dessouki, John D. Dickinson, Brian Do, Michael Dollin, Pravin U. Dugel and 297 more - Ophthalmology 2023 cited by 138

  14. Imaging Features Associated with Progression to Geographic Atrophy in Age-Related Macular Degeneration

    Authors: , , , , , , , , , , , , , , - Ophthalmology Retina 2020 cited by 158

  15. Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration

    Authors: , , , , , , , , , , , , , , , , , , , , , - Ophthalmology 2013 cited by 811

  16. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial

    Authors: , , , , , , , , , , , , , , , - The Lancet 2016 cited by 512

  17. Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study

    Authors: , , , , , , , , , , , - The Lancet 2024 cited by 119

  18. Retinal Vasculitis After Intravitreal Pegcetacoplan: Report From the ASRS Research and Safety in Therapeutics (ReST) Committee

    Authors: , , , , - Journal of VitreoRetinal Diseases 2023 cited by 59

  19. Imaging Protocols in Clinical Studies in Advanced Age-Related Macular Degeneration

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Ophthalmology 2017 cited by 233

  20. Risk of Scar in the Comparison of Age-related Macular Degeneration Treatments Trials

    Authors: , , , , , , , , , , - Ophthalmology 2013 cited by 326

  21. Natural History of Geographic Atrophy Progression Secondary to Age-Related Macular Degeneration (Geographic Atrophy Progression Study)

    Authors: , , , , , , , - Ophthalmology 2015 cited by 213

  22. Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephanie Schindeldecker, John Snater, Trenise Steele, Dwight Selders, Jessica Tonsfeldt, Shelly Valardi, Gary E. Fish, Hank A. Aguado, Sally Arceneaux, Jean Arnwine, Kim Bell, Tina Bell, Bob Boleman, Patricia Bradley, David Callanan, Lori Coors, Jodi Creighton, Timothy Crew, Kimberly Cummings, Christopher Dock, Karen Duignan, Dwain Fuller, Keith Gray, Betsy Hendrix, Nicholas Hesse, Diana Jaramillo, Bradley F. Jost, Sandy Lash, Laura Lonsdale, Michael Mackens, Karin Mutz, Michael Potts, Brenda Sanchez, William B. Snyder, Wayne Solley, Carrie Tarter, Robert Wang, Patrick Williams, Stephen L. Perkins, Nicholas G. Anderson, Ann Arnold, Paul Blais, Joseph M. Googe, Tina T. Higdon, Cecile Hunt, Mary A. Johnson, James Miller, Misty Moore, Charity K. Morris, Christopher Morris, Sarah Oelrich, Kristina Oliver, Vicky Seitz, Jerry Whetstone, Bernard H. Doft, Jay Bedel, Robert L. Bergren, Ann Borthwick, Paul Conrad, Amanda Fec, Christina Fulwylie, Willia Ingram, Shawnique Latham, Gina Lester, Judy Liu, Louis A. Lobes, Nicole M. Lucko, Holly Mechling, Lori Merlotti, Keith McBroom and 802 more - Ophthalmology 2015 cited by 212

  23. Intravitreal Aflibercept for Diabetic Macular Edema

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Ophthalmology 2014 cited by 807

  24. Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials

    Authors: , , , , , , , , , , , , - Ophthalmology 2013 cited by 585